Genetic predisposition to accelerated decline of lung function in COPD

Keywords

COPD, Medicine, Genetic predisposition, Lung function, Disease

References

• Susceptibility genes for rapid decline of lung function in the lung health study.George Ioannidis, Thorsten Hermes, Andrea Miene — 2001
• The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function.R G Allakhverdyan, А. Н. Ораевский, A F Suchkov — 2002
• Relationship between polymorphisms of genes encoding microsomal epoxide hydrolase and glutathione S-transferase P1 and chronic obstructive pulmonary disease.肖丹, Chen Wang, 杜敏捷 — 2004
• Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPDPaula Rytilä, Tiina Rehn, Helen Ilumets — 2006
• Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease.Tom Wilkinson, Irem Patel, Mark Wilks — 2003
• Smoking and lung function of Lung Health Study participants after 11 years.Nicholas R. Anthonisen, John E. Connett, Robert P. Murray — 2002
• A single nucleotide polymorphism in the CCL1 gene predicts acute exacerbations in chronic obstructive pulmonary disease.Noriaki Takabatake, Yoko Shibata, Shuichi Abe — 2006
• Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.N. R. ANTHOISEN, John E. Connett, James P. Kiley — 1995
• Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema.Christopher A. Smith, David J. Harrison — 1997
• Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema.Norihiro Yamada, Mutsuo Yamaya, Shoji Okinaga — 2000
• Oxidative stress indices in COPD--Broncho-alveolar lavage and salivary analysis.Mordechai Yigla, Yaron Berkovich, Rafael M. Nagler — 2007
• Genes, oxidative stress, and the risk of chronic obstructive pulmonary diseaseHiroshi Koyama, D M Geddes — 1998
• Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseGavin C. Donaldson — 2002
• Smoking reduction and the rate of decline in FEV1: results from the Lung Health StudyM Simmons, John E. Connett, Mitchell Nides — 2005
• Genome-Wide RNAi Screen for Host Factors Required for Intracellular Bacterial InfectionHervé Agaisse, Laura S. Burrack, Jennifer A. Philips — 2005
• Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.Richard E. Kanner, Nicholas R. Anthonisen, John E. Connett — 2001
• Association of lung function decline with the heme oxygenase-1 gene promoter microsatellite polymorphism in a general population sample. Results from the European Community Respiratory Health Survey (ECRHS), FranceArmelle Guénégou, B Leynaert, J Bénessiano — 2006
• Polymorphisms in the β2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokersL. Joós — 2003
• Bronchodilator response in the lung health study over 11 yrsNicholas R. Anthonisen, P. G. Lindgren, Donald P. Tashkin — 2005
• Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers.Jian‐Qing He, Jian Ruan, John E. Connett — 2002

Cited by

• Association between baseline airflow obstruction and rate of decline in lung function.誠一 斎藤 — 2012
• LUNG PHYSIOLOGY and AIRWAY INFLAMMATION INCOPD PATIENTS WITH PERSISTENT SPUTUM PRODUCTIONShruti Khurana — 2013
• Defining the Pulmonary Disease and Disability from Lung Dysfunction in Cutis LaxaMac Neal, Meghan Kelly — 2012
• Role of oxidative stress & transient receptor potential in chronic obstructive pulmonary diseaseProtiti Bose, Rashmi Bathri, Lalit Kumar — 2015
• Asthma and chronic obstructive pulmonary disease: common genes, common environments?Dirkje S. Postma, Marjan Kerkhof, H. Marike Boezen — 2011
• Genome-wide study identifies two loci associated with lung function decline in mild to moderate COPDNadia N. Hansel, Ingo Ruczinski, Nicholas Rafaels — 2012
• Serum Vitamin D in Patients with Chronic Obstructive Lung Disease Does Not Correlate with Mortality – Results from a 10-Year Prospective Cohort StudyDennis Back Holmgaard, Lone Hagens Mygind, Ingrid Louise Titlestad — 2013
• Lungenfunktion im Alter: Brauchen wir neue Referenzwerte?W. Marek, E Marek, K Mückenhoff — 2009
• Pharmacogenetics in drug discovery and development: a translational perspectiveAllen D. Roses — 2008
• Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema.Marco Chilosi, Angelo Carloni, Andrea Rossi — 2013
• Time for new reference values for ventilatory lung functionW. Marek, E Marek, K Mückenhoff — 2009
• Antibiotic Therapy for Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)B. Butorac-Petanjek, Michael J. Parnham, Sanja Popović‐Grle — 2010
• Lung function in our aging populationW. Marek, EM Marek, K Mückenhoff — 2011
• Asthma and COPD: Common Genes, Common Environments?Dirkje S. Postma, Marjan Kerkhof, H. Marike Boezen — 2011
• Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research – a consensus document from six scientific societiesAndrea Rossi, Bojana Butorac Petanjek, Marco Chilosi — 2017
• Chronic obstructive pulmonary disease and risk factors-with reference to gender, socioeconomic status and educational levels: A hospital based studyShah Mohammad Abbas Waseem, VK Srivastava, Rubeena Bano — 2017
• Diagnosis and Treatment of Early Chronic Obstructive Lung Disease (COPD)Joon Young Choi, Chin Kook Rhee — 2020
• A Systematic Literature Review of the Humanistic Burden of COPDJohn R. Hurst, Mohd Kashif Siddiqui, Barinder Singh — 2021
• Bronchial gene expression signature associated with rate of subsequent FEV1 decline in individuals with and at risk of COPDElizabeth J. Becker, Alen Faiz, Maarten van den Berge — 2021
• Exosomes in chronic respiratory diseases.Beatrice Purghè, Marcello Manfredi, Beatrice Ragnoli — 2021

Related papers

• Exacerbations in chronic obstructive pulmonary disease: do they contribute to disease progression?Edwin K. Silverman — 2007
• Approaches to slowing the progression of COPDMurray D. Altose — 2003
• Can we delay the accelerated lung aging in COPD? Anti-aging molecules and interventions.Andriana Ι. Papaioannou, Christos Rossios, Κonstantinos Κostikas — 2013
• Genetics of COPD: present and future.John R. Hoidal — 2001
• Chronic obstructive pulmonary disease as a risk factor for lung cancer.Yuichi Takiguchi — 2014
• The natural history of chronic airflow obstruction.C. M. Fletcher, Richárd Pető — 1977
• Asthma and Chronic Obstructive Pulmonary Disease (COPD) – Differences and SimilaritiesVesna Čukić, Vladimir Lovre, Dejan Dragisic — 2012
• TB meets COPD: An emerging global co-morbidity in human lung disease.Ronan O’Toole, Shakti D. Shukla, E. Haydn Walters — 2015
• ROLE OF GENETIC SUSCEPTIBILITY IN NICOTINE ADDICTION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE.Gloría Pérez-Rubio, Elizabeth Córdoba-Lanús, Paula Cupertino — 2019